Cite
HARVARD Citation
Sellam, J. et al. (2014). Use of Whole‐Blood Transcriptomic Profiling to Highlight Several Pathophysiologic Pathways Associated With Response to Rituximab in Patients With Rheumatoid Arthritis: Data From a Randomized, Controlled, Open‐Label Trial1. Arthritis & rheumatology. 66 (8), pp. 2015-2025. [Online].